Wilmington, DE, United States of America

Kwaku O Temeng

This inventor holds 1 USPTO granted patent. Top assignee: E.i. Dupont De Nemours and Company. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kwaku O Temeng: Innovator in Sulfonylurea Preparation

Introduction

Kwaku O Temeng is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of chemistry, particularly in the preparation of sulfonylureas. His innovative approach has led to advancements in pharmaceutical processes.

Latest Patents

Kwaku O Temeng holds 1 patent for his invention titled "Process for preparing sulfonylureas." This invention involves a method of reacting a sulfonyl chloride with a cyanate salt and an amine base in the presence of an inert aprotic solvent. The process results in the formation of an isocyanate complex, which is subsequently reacted with an amino heterocycle to produce the sulfonylurea product. Additionally, he has developed a process for converting the crystal form of the prepared sulfonylurea product into a more stable crystal product form.

Career Highlights

Kwaku O Temeng is associated with E.I. DuPont De Nemours and Company, where he has contributed to various research initiatives. His work has been instrumental in enhancing the efficiency and effectiveness of chemical processes within the company.

Collaborations

Some of his notable coworkers include George C Chiang and Richard F Davis. Their collaborative efforts have furthered the research and development of innovative chemical processes.

Conclusion

Kwaku O Temeng's contributions to the field of chemistry, particularly in the preparation of sulfonylureas, highlight his role as an influential inventor. His innovative processes continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…